{"transactions":[{"id":942525,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-09T22:25:30.000Z","date":"2026-01-07","kind":"purchase","planned":false,"acquired":true,"shares":46337,"price":18.11,"value":839163.07,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.80 to $18.21 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held of record by Andreessen Horowitz LSV Fund II, L.P. (\"AH LSV Fund II\"), for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the \"AH LSV Fund II Entities\"). AH Equity Partners LSV II, L.L.C. (\"AH EP LSV II \"), the general partner of AH LSV Fund II, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund II Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV II and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund II Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":8346792,"source":{"system":"sec-edgar","filing":"0001231919-26-000037","document":"form4-01092026_050119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191926000037/form4-01092026_050119.xml","form_type":"4"}},{"id":947547,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-06T23:55:27.000Z","date":"2026-01-06","kind":"purchase","planned":false,"acquired":true,"shares":308188,"price":16.74,"value":5159067.12,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.28 to $17.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held of record by Andreessen Horowitz LSV Fund II, L.P. (\"AH LSV Fund II\"), for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the \"AH LSV Fund II Entities\"). AH Equity Partners LSV II, L.L.C. (\"AH EP LSV II \"), the general partner of AH LSV Fund II, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund II Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV II and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund II Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":8300455,"source":{"system":"sec-edgar","filing":"0001231919-26-000015","document":"form4-01062026_060117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191926000015/form4-01062026_060117.xml","form_type":"4"}},{"id":947546,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-06T23:55:27.000Z","date":"2026-01-05","kind":"purchase","planned":false,"acquired":true,"shares":202729,"price":15.77,"value":3197036.33,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.59 to $16.47 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held of record by Andreessen Horowitz LSV Fund II, L.P. (\"AH LSV Fund II\"), for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the \"AH LSV Fund II Entities\"). AH Equity Partners LSV II, L.L.C. (\"AH EP LSV II \"), the general partner of AH LSV Fund II, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund II Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV II and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund II Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":7992267,"source":{"system":"sec-edgar","filing":"0001231919-26-000015","document":"form4-01062026_060117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191926000015/form4-01062026_060117.xml","form_type":"4"}},{"id":947545,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-06T23:55:27.000Z","date":"2026-01-02","kind":"purchase","planned":false,"acquired":true,"shares":466058,"price":16.27,"value":7582763.66,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.10 to $16.50 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held of record by Andreessen Horowitz LSV Fund II, L.P. (\"AH LSV Fund II\"), for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the \"AH LSV Fund II Entities\"). AH Equity Partners LSV II, L.L.C. (\"AH EP LSV II \"), the general partner of AH LSV Fund II, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund II Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV II and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund II Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":7789538,"source":{"system":"sec-edgar","filing":"0001231919-26-000015","document":"form4-01062026_060117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191926000015/form4-01062026_060117.xml","form_type":"4"}},{"id":958539,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-29T23:15:25.000Z","date":"2025-12-29","kind":"purchase","planned":false,"acquired":true,"shares":99502,"price":16.16,"value":1607952.32,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.84 to $16.50 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held of record by Andreessen Horowitz LSV Fund II, L.P. (\"AH LSV Fund II\"), for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the \"AH LSV Fund II Entities\"). AH Equity Partners LSV II, L.L.C. (\"AH EP LSV II \"), the general partner of AH LSV Fund II, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund II Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV II and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund II Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":7323480,"source":{"system":"sec-edgar","filing":"0001231919-25-000664","document":"form4-12292025_061215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000664/form4-12292025_061215.xml","form_type":"4"}},{"id":958538,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-29T23:15:25.000Z","date":"2025-12-26","kind":"purchase","planned":false,"acquired":true,"shares":229917,"price":15.57,"value":3579807.69,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.48 to $15.85 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held of record by Andreessen Horowitz LSV Fund II, L.P. (\"AH LSV Fund II\"), for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the \"AH LSV Fund II Entities\"). AH Equity Partners LSV II, L.L.C. (\"AH EP LSV II \"), the general partner of AH LSV Fund II, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund II Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV II and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund II Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":7223978,"source":{"system":"sec-edgar","filing":"0001231919-25-000664","document":"form4-12292025_061215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000664/form4-12292025_061215.xml","form_type":"4"}},{"id":958537,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-29T23:15:25.000Z","date":"2025-12-24","kind":"purchase","planned":false,"acquired":true,"shares":167519,"price":15.83,"value":2651825.77,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.69 to $16.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held of record by Andreessen Horowitz LSV Fund II, L.P. (\"AH LSV Fund II\"), for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the \"AH LSV Fund II Entities\"). AH Equity Partners LSV II, L.L.C. (\"AH EP LSV II \"), the general partner of AH LSV Fund II, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund II Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV II and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund II Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":6994061,"source":{"system":"sec-edgar","filing":"0001231919-25-000664","document":"form4-12292025_061215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000664/form4-12292025_061215.xml","form_type":"4"}},{"id":958536,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-29T23:15:25.000Z","date":"2025-12-23","kind":"purchase","planned":false,"acquired":true,"shares":225484,"price":15.84,"value":3571666.56,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.52 to $16.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held of record by Andreessen Horowitz LSV Fund II, L.P. (\"AH LSV Fund II\"), for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the \"AH LSV Fund II Entities\"). AH Equity Partners LSV II, L.L.C. (\"AH EP LSV II \"), the general partner of AH LSV Fund II, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund II Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV II and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund II Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":6826542,"source":{"system":"sec-edgar","filing":"0001231919-25-000664","document":"form4-12292025_061215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000664/form4-12292025_061215.xml","form_type":"4"}},{"id":958535,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-29T23:15:25.000Z","date":"2025-12-22","kind":"purchase","planned":false,"acquired":true,"shares":334112,"price":15.9,"value":5312380.8,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.65 to $16.23 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held of record by Andreessen Horowitz LSV Fund II, L.P. (\"AH LSV Fund II\"), for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the \"AH LSV Fund II Entities\"). AH Equity Partners LSV II, L.L.C. (\"AH EP LSV II \"), the general partner of AH LSV Fund II, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund II Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV II and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund II Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":6601058,"source":{"system":"sec-edgar","filing":"0001231919-25-000664","document":"form4-12292025_061215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000664/form4-12292025_061215.xml","form_type":"4"}},{"id":962300,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-20T01:25:12.000Z","date":"2025-12-19","kind":"purchase","planned":false,"acquired":true,"shares":240835,"price":14.7,"value":3540274.5,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.44 to $15.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held of record by Andreessen Horowitz LSV Fund II, L.P. (\"AH LSV Fund II\"), for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the \"AH LSV Fund II Entities\"). AH Equity Partners LSV II, L.L.C. (\"AH EP LSV II \"), the general partner of AH LSV Fund II, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund II Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV II and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund II Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":6266946,"source":{"system":"sec-edgar","filing":"0001231919-25-000648","document":"form4-12192025_081201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000648/form4-12192025_081201.xml","form_type":"4"}},{"id":962299,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-20T01:25:12.000Z","date":"2025-12-18","kind":"purchase","planned":false,"acquired":true,"shares":103960,"price":13.61,"value":1414895.6,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.93 to $13.90 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held of record by Andreessen Horowitz LSV Fund II, L.P. (\"AH LSV Fund II\"), for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the \"AH LSV Fund II Entities\"). AH Equity Partners LSV II, L.L.C. (\"AH EP LSV II \"), the general partner of AH LSV Fund II, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund II Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV II and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund II Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":6026111,"source":{"system":"sec-edgar","filing":"0001231919-25-000648","document":"form4-12192025_081201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000648/form4-12192025_081201.xml","form_type":"4"}},{"id":962298,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-20T01:25:12.000Z","date":"2025-12-17","kind":"purchase","planned":false,"acquired":true,"shares":347600,"price":12.65,"value":4397140.0,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.48 to $12.90 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held of record by Andreessen Horowitz LSV Fund II, L.P. (\"AH LSV Fund II\"), for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the \"AH LSV Fund II Entities\"). AH Equity Partners LSV II, L.L.C. (\"AH EP LSV II \"), the general partner of AH LSV Fund II, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund II Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV II and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund II Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":5922151,"source":{"system":"sec-edgar","filing":"0001231919-25-000648","document":"form4-12192025_081201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000648/form4-12192025_081201.xml","form_type":"4"}},{"id":1008539,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series G-1 Preferred Stock","published_at":"2025-11-05T00:42:35.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":false,"shares":1201643,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held of record by Andreessen Horowitz LSV Fund III, L.P. (\"AH LSV Fund III\"), for itself and as nominee for Andreessen Horowitz LSV Fund III-B, L.P., AH 2022 Annual Fund, L.P., AH 2022 Annual Fund-B, L.P. and AH 2022 Annual Fund-QC, L.P. (collectively, the \"AH LSV Fund III Entities\"). AH Equity Partners LSV III, L.L.C. (\"AH EP LSV III\"), the general partner of AH LSV Fund III, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund III Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"(Continued from Footnote 4) Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV III and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund III Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund III Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":405855},"source":{"system":"sec-edgar","filing":"0001231919-25-000424","document":"form4-11052025_121124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000424/form4-11052025_121124.xml","form_type":"4"}},{"id":1008538,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Preferred Stock","published_at":"2025-11-05T00:42:35.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":false,"shares":9274,"ownership":{"direct":false,"nature":"By CLF Partners, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"These shares are held of record by CLF Partners, LP (\"CLF\"). AH EP V, the general partner of CLF, may be deemed to have sole voting and dispositive power over the shares held by CLF. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP V and may be deemed to have shared voting and dispositive power over the shares held by CLF. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by CLF and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3123},"source":{"system":"sec-edgar","filing":"0001231919-25-000424","document":"form4-11052025_121124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000424/form4-11052025_121124.xml","form_type":"4"}},{"id":1008537,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Preferred Stock","published_at":"2025-11-05T00:42:35.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":false,"shares":2309297,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held of record by Andreessen Horowitz LSV Fund II, L.P. (\"AH LSV Fund II\"), for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the \"AH LSV Fund II Entities\"). AH Equity Partners LSV II, L.L.C. (\"AH EP LSV II \"), the general partner of AH LSV Fund II, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund II Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV II and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund II Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":777832},"source":{"system":"sec-edgar","filing":"0001231919-25-000424","document":"form4-11052025_121124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000424/form4-11052025_121124.xml","form_type":"4"}},{"id":1008536,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Stock","published_at":"2025-11-05T00:42:35.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":false,"shares":9763156,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held of record by Andreessen Horowitz LSV Fund II, L.P. (\"AH LSV Fund II\"), for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the \"AH LSV Fund II Entities\"). AH Equity Partners LSV II, L.L.C. (\"AH EP LSV II \"), the general partner of AH LSV Fund II, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund II Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV II and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund II Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3272830},"source":{"system":"sec-edgar","filing":"0001231919-25-000424","document":"form4-11052025_121124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000424/form4-11052025_121124.xml","form_type":"4"}},{"id":1008535,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2025-11-05T00:42:35.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":false,"shares":20244280,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund I, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held of record by Andreessen Horowitz LSV Fund I, L.P. (\"AH LSV Fund I\"), for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the \"AH LSV Fund I Entities\"). AH Equity Partners LSV I, L.L.C. (\"AH EP LSV I\"), the general partner of AH LSV Fund I, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6757090},"source":{"system":"sec-edgar","filing":"0001231919-25-000424","document":"form4-11052025_121124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000424/form4-11052025_121124.xml","form_type":"4"}},{"id":1008534,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2025-11-05T00:42:35.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":false,"shares":41635,"ownership":{"direct":false,"nature":"By CLF Partners, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"These shares are held of record by CLF Partners, LP (\"CLF\"). AH EP V, the general partner of CLF, may be deemed to have sole voting and dispositive power over the shares held by CLF. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP V and may be deemed to have shared voting and dispositive power over the shares held by CLF. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by CLF and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":13878},"source":{"system":"sec-edgar","filing":"0001231919-25-000424","document":"form4-11052025_121124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000424/form4-11052025_121124.xml","form_type":"4"}},{"id":1008533,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2025-11-05T00:42:35.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":false,"shares":31226580,"ownership":{"direct":false,"nature":"By AH Parallel Fund V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"These shares are held of record by AH Parallel Fund V, L.P. (\"AH Parallel V\"), for itself and as nominee for AH Parallel Fund V-A, L.P., AH Parallel Fund V-B, L.P., and AH Parallel Fund V-Q, L.P. (collectively, the \"AH Parallel Fund V Entities\"). AH Equity Partners V (Parallel), L.L.C. (\"AH EP V Parallel\"), the general partner of AH Parallel V, may be deemed to have sole voting and dispositive power over the shares held by the AH Parallel Fund V Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP V Parallel and may be deemed to have shared voting and dispositive power over the shares held by the AH Parallel Fund V Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"(Continued from Footnote 8) Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH Parallel Fund V Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":10408860},"source":{"system":"sec-edgar","filing":"0001231919-25-000424","document":"form4-11052025_121124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000424/form4-11052025_121124.xml","form_type":"4"}},{"id":1008532,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2025-11-05T00:42:35.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":false,"shares":6245316,"ownership":{"direct":false,"nature":"By Andreessen Horowitz Fund V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are held of record by Andreessen Horowitz Fund V, L.P. (\"AH Fund V\"), for itself and as nominee for Andreessen Horowitz Fund V-A, L.P., Andreessen Horowitz Fund V-B, L.P. and Andreessen Horowitz Fund V-Q, L.P. (collectively, the \"AH Fund V Entities\"). AH Equity Partners V, L.L.C. (\"AH EP V\"), the general partner of AH Fund V, may be deemed to have sole voting and dispositive power over the shares held by the AH Fund V Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP V and may be deemed to have shared voting and dispositive power over the shares held by the AH Fund V Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH Fund V Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2081772},"source":{"system":"sec-edgar","filing":"0001231919-25-000424","document":"form4-11052025_121124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000424/form4-11052025_121124.xml","form_type":"4"}},{"id":1008531,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2025-11-05T00:42:35.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":false,"shares":603920,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held of record by Andreessen Horowitz LSV Fund III, L.P. (\"AH LSV Fund III\"), for itself and as nominee for Andreessen Horowitz LSV Fund III-B, L.P., AH 2022 Annual Fund, L.P., AH 2022 Annual Fund-B, L.P. and AH 2022 Annual Fund-QC, L.P. (collectively, the \"AH LSV Fund III Entities\"). AH Equity Partners LSV III, L.L.C. (\"AH EP LSV III\"), the general partner of AH LSV Fund III, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund III Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"(Continued from Footnote 4) Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV III and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund III Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund III Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":201306},"source":{"system":"sec-edgar","filing":"0001231919-25-000424","document":"form4-11052025_121124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000424/form4-11052025_121124.xml","form_type":"4"}},{"id":1008530,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series Seed Preferred Stock","published_at":"2025-11-05T00:42:35.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":false,"shares":765736,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held of record by Andreessen Horowitz LSV Fund II, L.P. (\"AH LSV Fund II\"), for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the \"AH LSV Fund II Entities\"). AH Equity Partners LSV II, L.L.C. (\"AH EP LSV II \"), the general partner of AH LSV Fund II, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund II Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV II and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund II Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":255244},"source":{"system":"sec-edgar","filing":"0001231919-25-000424","document":"form4-11052025_121124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000424/form4-11052025_121124.xml","form_type":"4"}},{"id":1008529,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-05T00:42:35.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":true,"shares":10408860,"ownership":{"direct":false,"nature":"By AH Parallel Fund V, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"These shares are held of record by AH Parallel Fund V, L.P. (\"AH Parallel V\"), for itself and as nominee for AH Parallel Fund V-A, L.P., AH Parallel Fund V-B, L.P., and AH Parallel Fund V-Q, L.P. (collectively, the \"AH Parallel Fund V Entities\"). AH Equity Partners V (Parallel), L.L.C. (\"AH EP V Parallel\"), the general partner of AH Parallel V, may be deemed to have sole voting and dispositive power over the shares held by the AH Parallel Fund V Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP V Parallel and may be deemed to have shared voting and dispositive power over the shares held by the AH Parallel Fund V Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"(Continued from Footnote 8) Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH Parallel Fund V Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":10408860,"source":{"system":"sec-edgar","filing":"0001231919-25-000424","document":"form4-11052025_121124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000424/form4-11052025_121124.xml","form_type":"4"}},{"id":1008528,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-05T00:42:35.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":true,"shares":17001,"ownership":{"direct":false,"nature":"By CLF Partners, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"These shares are held of record by CLF Partners, LP (\"CLF\"). AH EP V, the general partner of CLF, may be deemed to have sole voting and dispositive power over the shares held by CLF. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP V and may be deemed to have shared voting and dispositive power over the shares held by CLF. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by CLF and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":17001,"source":{"system":"sec-edgar","filing":"0001231919-25-000424","document":"form4-11052025_121124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000424/form4-11052025_121124.xml","form_type":"4"}},{"id":1008527,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-05T00:42:35.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":true,"shares":2081772,"ownership":{"direct":false,"nature":"By Andreessen Horowitz Fund V, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are held of record by Andreessen Horowitz Fund V, L.P. (\"AH Fund V\"), for itself and as nominee for Andreessen Horowitz Fund V-A, L.P., Andreessen Horowitz Fund V-B, L.P. and Andreessen Horowitz Fund V-Q, L.P. (collectively, the \"AH Fund V Entities\"). AH Equity Partners V, L.L.C. (\"AH EP V\"), the general partner of AH Fund V, may be deemed to have sole voting and dispositive power over the shares held by the AH Fund V Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP V and may be deemed to have shared voting and dispositive power over the shares held by the AH Fund V Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH Fund V Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":2081772,"source":{"system":"sec-edgar","filing":"0001231919-25-000424","document":"form4-11052025_121124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000424/form4-11052025_121124.xml","form_type":"4"}},{"id":1008526,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-05T00:42:35.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":true,"shares":607161,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held of record by Andreessen Horowitz LSV Fund III, L.P. (\"AH LSV Fund III\"), for itself and as nominee for Andreessen Horowitz LSV Fund III-B, L.P., AH 2022 Annual Fund, L.P., AH 2022 Annual Fund-B, L.P. and AH 2022 Annual Fund-QC, L.P. (collectively, the \"AH LSV Fund III Entities\"). AH Equity Partners LSV III, L.L.C. (\"AH EP LSV III\"), the general partner of AH LSV Fund III, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund III Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"(Continued from Footnote 4) Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV III and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund III Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund III Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":607161,"source":{"system":"sec-edgar","filing":"0001231919-25-000424","document":"form4-11052025_121124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000424/form4-11052025_121124.xml","form_type":"4"}},{"id":1008525,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-05T00:42:35.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":true,"shares":4305906,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held of record by Andreessen Horowitz LSV Fund II, L.P. (\"AH LSV Fund II\"), for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the \"AH LSV Fund II Entities\"). AH Equity Partners LSV II, L.L.C. (\"AH EP LSV II \"), the general partner of AH LSV Fund II, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund II Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV II and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund II Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":5574551,"source":{"system":"sec-edgar","filing":"0001231919-25-000424","document":"form4-11052025_121124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000424/form4-11052025_121124.xml","form_type":"4"}},{"id":1008524,"issuer":{"id":3707,"kind":"organization","name":"Navan, Inc.","symbol":"NAVN"},"owners":[{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":1,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":2,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":3,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":4,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":5,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":6,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":7,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":8,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-05T00:42:35.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":true,"shares":6757090,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund I, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed, Series A, Series C, Series D, Series E, Series F and Series G-1 Preferred Stock automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") for no additional consideration at a conversion ratio that was dependent upon the initial offering price per share of the Class A Common Stock to the public in the Issuer's IPO, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held of record by Andreessen Horowitz LSV Fund I, L.P. (\"AH LSV Fund I\"), for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the \"AH LSV Fund I Entities\"). AH Equity Partners LSV I, L.L.C. (\"AH EP LSV I\"), the general partner of AH LSV Fund I, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":6757090,"source":{"system":"sec-edgar","filing":"0001231919-25-000424","document":"form4-11052025_121124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000123191925000424/form4-11052025_121124.xml","form_type":"4"}},{"id":1745947,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":1,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":2,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":3,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":4,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":5,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":6,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":7,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":8,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":20480,"kind":"person","name":"HOROWITZ BENJAMIN A","position":10,"cik":"0001166586","reported_name":"HOROWITZ BENJAMIN A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Earn-out Shares","published_at":"2023-11-09T21:06:10.000Z","date":"2023-11-09","kind":"other","planned":false,"acquired":false,"shares":1574510,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund I, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F12","text":"Pursuant to the terms of the Agreement and Plan of Merger dated August 5, 2021 (the \"DeSPAC Merger Agreement\"), by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.), AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the \"AH Funds\") were allocated the right to acquire an aggregate of 6,618,825 shares of Issuer common stock (the \"Earn-out Shares\"), (i) 4,633,177 of which will be released from escrow if the value weighted average price (\"VWAP\") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 1,985,648 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F13","text":"Any Earn-out Shares not eligible to be released from escrow on or prior to the Effective Time, together with any other right, title or interest in or to such Earn-out Shares, are waived by the AH Funds and terminated."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the \"Merger Agreement\"), by and among the Issuer, Revolution Medicines, Inc. (\"Revolution Medicines\"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines (\"Merger Sub I\"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines (\"Merger Sub II\"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the \"Effective Time\"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the \"First Merger\"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the \"Exchange Ratio\") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Pursuant to the terms of the Agreement and Plan of Merger dated August 5, 2021 (the \"DeSPAC Merger Agreement\"), by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.), AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the \"AH Funds\") were allocated the right to acquire an aggregate of 6,618,825 shares of Issuer common stock (the \"Earn-out Shares\"), (i) 4,633,177 of which will be released from escrow if the value weighted average price (\"VWAP\") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 1,985,648 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Any Earn-out Shares not eligible to be released from escrow on or prior to the Effective Time, together with any other right, title or interest in or to such Earn-out Shares, are waived by the AH Funds and terminated."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time and held in escrow subject to the earn-out on the terms and subject to the conditions of the DeSPAC Merger Agreement was converted in the same manner as all other shares of Issuer common stock under the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the \"Exchange Ratio\") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"Each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time and held in escrow subject to the earn-out on the terms and subject to the conditions of the DeSPAC Merger Agreement was converted in the same manner as all other shares of Issuer common stock under the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The reported securities are held by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the \"AH LSV Fund I Entities\"). AH Equity Partners LSV I, L.L.C. (\"AH EP LSV I\") is the general partner of the AH LSV Fund I Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH LSV Fund I Entities. The managing members of AH EP LSV I are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH LSV Fund I Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"expiration_date":"2024-12-17","underlying":"Common Stock","underlying_shares":1574510},"source":{"system":"sec-edgar","filing":"0000899243-23-020291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000089924323020291/doc4.xml","form_type":"4"}},{"id":1745946,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":1,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":2,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":3,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":4,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":5,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":6,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":7,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":8,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":20480,"kind":"person","name":"HOROWITZ BENJAMIN A","position":10,"cik":"0001166586","reported_name":"HOROWITZ BENJAMIN A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Earn-out Shares","published_at":"2023-11-09T21:06:10.000Z","date":"2023-11-09","kind":"other","planned":false,"acquired":false,"shares":2642897,"ownership":{"direct":false,"nature":"By AH Bio Fund III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F12","text":"Pursuant to the terms of the Agreement and Plan of Merger dated August 5, 2021 (the \"DeSPAC Merger Agreement\"), by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.), AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the \"AH Funds\") were allocated the right to acquire an aggregate of 6,618,825 shares of Issuer common stock (the \"Earn-out Shares\"), (i) 4,633,177 of which will be released from escrow if the value weighted average price (\"VWAP\") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 1,985,648 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F13","text":"Any Earn-out Shares not eligible to be released from escrow on or prior to the Effective Time, together with any other right, title or interest in or to such Earn-out Shares, are waived by the AH Funds and terminated."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the \"Merger Agreement\"), by and among the Issuer, Revolution Medicines, Inc. (\"Revolution Medicines\"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines (\"Merger Sub I\"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines (\"Merger Sub II\"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the \"Effective Time\"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the \"First Merger\"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the \"Exchange Ratio\") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Pursuant to the terms of the Agreement and Plan of Merger dated August 5, 2021 (the \"DeSPAC Merger Agreement\"), by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.), AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the \"AH Funds\") were allocated the right to acquire an aggregate of 6,618,825 shares of Issuer common stock (the \"Earn-out Shares\"), (i) 4,633,177 of which will be released from escrow if the value weighted average price (\"VWAP\") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 1,985,648 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Any Earn-out Shares not eligible to be released from escrow on or prior to the Effective Time, together with any other right, title or interest in or to such Earn-out Shares, are waived by the AH Funds and terminated."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time and held in escrow subject to the earn-out on the terms and subject to the conditions of the DeSPAC Merger Agreement was converted in the same manner as all other shares of Issuer common stock under the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the \"Exchange Ratio\") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"Each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time and held in escrow subject to the earn-out on the terms and subject to the conditions of the DeSPAC Merger Agreement was converted in the same manner as all other shares of Issuer common stock under the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The reported securities are held by AH Bio Fund III, L.P., for itself and as nominee for AH Bio Fund III-B, L.P. and AH Bio Fund III-Q, L.P. (collectively, the \"AH Bio Fund III Entities\"). AH Equity Partners Bio III, L.L.C. (\"AH EP Bio III\") is the general partner of the AH Bio Fund III Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH Bio Fund III Entities. The managing members of AH EP Bio III are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH Bio Fund III Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH Bio Fund III Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"expiration_date":"2024-12-17","underlying":"Common Stock","underlying_shares":2642897},"source":{"system":"sec-edgar","filing":"0000899243-23-020291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000089924323020291/doc4.xml","form_type":"4"}},{"id":1745945,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":1,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":2,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":3,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":4,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":5,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":6,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":7,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":8,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":20480,"kind":"person","name":"HOROWITZ BENJAMIN A","position":10,"cik":"0001166586","reported_name":"HOROWITZ BENJAMIN A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Earn-out Shares","published_at":"2023-11-09T21:06:10.000Z","date":"2023-11-09","kind":"other","planned":false,"acquired":false,"shares":2401418,"ownership":{"direct":false,"nature":"By AH Bio Fund II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F12","text":"Pursuant to the terms of the Agreement and Plan of Merger dated August 5, 2021 (the \"DeSPAC Merger Agreement\"), by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.), AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the \"AH Funds\") were allocated the right to acquire an aggregate of 6,618,825 shares of Issuer common stock (the \"Earn-out Shares\"), (i) 4,633,177 of which will be released from escrow if the value weighted average price (\"VWAP\") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 1,985,648 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F13","text":"Any Earn-out Shares not eligible to be released from escrow on or prior to the Effective Time, together with any other right, title or interest in or to such Earn-out Shares, are waived by the AH Funds and terminated."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the \"Merger Agreement\"), by and among the Issuer, Revolution Medicines, Inc. (\"Revolution Medicines\"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines (\"Merger Sub I\"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines (\"Merger Sub II\"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the \"Effective Time\"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the \"First Merger\"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the \"Exchange Ratio\") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Pursuant to the terms of the Agreement and Plan of Merger dated August 5, 2021 (the \"DeSPAC Merger Agreement\"), by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.), AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the \"AH Funds\") were allocated the right to acquire an aggregate of 6,618,825 shares of Issuer common stock (the \"Earn-out Shares\"), (i) 4,633,177 of which will be released from escrow if the value weighted average price (\"VWAP\") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 1,985,648 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Any Earn-out Shares not eligible to be released from escrow on or prior to the Effective Time, together with any other right, title or interest in or to such Earn-out Shares, are waived by the AH Funds and terminated."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time and held in escrow subject to the earn-out on the terms and subject to the conditions of the DeSPAC Merger Agreement was converted in the same manner as all other shares of Issuer common stock under the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the \"Exchange Ratio\") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"Each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time and held in escrow subject to the earn-out on the terms and subject to the conditions of the DeSPAC Merger Agreement was converted in the same manner as all other shares of Issuer common stock under the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are held by AH Bio Fund II, L.P., for itself and as nominee for AH Bio Fund II-B, L.P. (collectively, the \"AH Bio Fund II Entities\"). AH Equity Partners Bio II, L.L.C. (\"AH EP Bio II\") is the general partner of the AH Bio Fund II Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH Bio Fund II Entities. The managing members of AH EP Bio II are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH Bio Fund II Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH Bio Fund II Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"expiration_date":"2024-12-17","underlying":"Common Stock","underlying_shares":2401418},"source":{"system":"sec-edgar","filing":"0000899243-23-020291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000089924323020291/doc4.xml","form_type":"4"}},{"id":1745944,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":1,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":2,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":3,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":4,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":5,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":6,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":7,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":8,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":20480,"kind":"person","name":"HOROWITZ BENJAMIN A","position":10,"cik":"0001166586","reported_name":"HOROWITZ BENJAMIN A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-09T21:06:10.000Z","date":"2023-11-09","kind":"other","planned":false,"acquired":false,"shares":5000000,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the \"Merger Agreement\"), by and among the Issuer, Revolution Medicines, Inc. (\"Revolution Medicines\"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines (\"Merger Sub I\"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines (\"Merger Sub II\"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the \"Effective Time\"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the \"First Merger\"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the \"Exchange Ratio\") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The reported securities are held by Andreessen Horowitz LSV Fund II, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the \"AH LSV Fund II Entities\"). AH Equity Partners LSV II, L.L.C. (\"AH EP LSV II\") is the general partner of the AH LSV Fund II Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH LSV Fund II Entities. The managing members of AH EP LSV II are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH LSV Fund II Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-020291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000089924323020291/doc4.xml","form_type":"4"}},{"id":1745943,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":1,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":2,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":3,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":4,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":5,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":6,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":7,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":8,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":20480,"kind":"person","name":"HOROWITZ BENJAMIN A","position":10,"cik":"0001166586","reported_name":"HOROWITZ BENJAMIN A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-09T21:06:10.000Z","date":"2023-11-09","kind":"other","planned":false,"acquired":false,"shares":11433677,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund I, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the \"Merger Agreement\"), by and among the Issuer, Revolution Medicines, Inc. (\"Revolution Medicines\"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines (\"Merger Sub I\"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines (\"Merger Sub II\"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the \"Effective Time\"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the \"First Merger\"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the \"Exchange Ratio\") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The reported securities are held by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the \"AH LSV Fund I Entities\"). AH Equity Partners LSV I, L.L.C. (\"AH EP LSV I\") is the general partner of the AH LSV Fund I Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH LSV Fund I Entities. The managing members of AH EP LSV I are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH LSV Fund I Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-020291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000089924323020291/doc4.xml","form_type":"4"}},{"id":1745942,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":1,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":2,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":3,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":4,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":5,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":6,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":7,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":8,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":20480,"kind":"person","name":"HOROWITZ BENJAMIN A","position":10,"cik":"0001166586","reported_name":"HOROWITZ BENJAMIN A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-09T21:06:10.000Z","date":"2023-11-09","kind":"other","planned":false,"acquired":false,"shares":19192015,"ownership":{"direct":false,"nature":"By AH Bio Fund III, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the \"Merger Agreement\"), by and among the Issuer, Revolution Medicines, Inc. (\"Revolution Medicines\"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines (\"Merger Sub I\"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines (\"Merger Sub II\"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the \"Effective Time\"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the \"First Merger\"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the \"Exchange Ratio\") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The reported securities are held by AH Bio Fund III, L.P., for itself and as nominee for AH Bio Fund III-B, L.P. and AH Bio Fund III-Q, L.P. (collectively, the \"AH Bio Fund III Entities\"). AH Equity Partners Bio III, L.L.C. (\"AH EP Bio III\") is the general partner of the AH Bio Fund III Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH Bio Fund III Entities. The managing members of AH EP Bio III are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH Bio Fund III Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH Bio Fund III Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-020291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000089924323020291/doc4.xml","form_type":"4"}},{"id":1745941,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":1,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":2,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":3,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":4,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":5,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":6,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":7,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":8,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":20480,"kind":"person","name":"HOROWITZ BENJAMIN A","position":10,"cik":"0001166586","reported_name":"HOROWITZ BENJAMIN A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-09T21:06:10.000Z","date":"2023-11-09","kind":"other","planned":false,"acquired":false,"shares":17438465,"ownership":{"direct":false,"nature":"By AH Bio Fund II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the \"Merger Agreement\"), by and among the Issuer, Revolution Medicines, Inc. (\"Revolution Medicines\"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines (\"Merger Sub I\"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines (\"Merger Sub II\"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the \"Effective Time\"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the \"First Merger\"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the \"Exchange Ratio\") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are held by AH Bio Fund II, L.P., for itself and as nominee for AH Bio Fund II-B, L.P. (collectively, the \"AH Bio Fund II Entities\"). AH Equity Partners Bio II, L.L.C. (\"AH EP Bio II\") is the general partner of the AH Bio Fund II Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH Bio Fund II Entities. The managing members of AH EP Bio II are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH Bio Fund II Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH Bio Fund II Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-020291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000089924323020291/doc4.xml","form_type":"4"}},{"id":1745940,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":1,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":2,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":3,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":4,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":5,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":6,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":7,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":8,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":20480,"kind":"person","name":"HOROWITZ BENJAMIN A","position":10,"cik":"0001166586","reported_name":"HOROWITZ BENJAMIN A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-09T21:06:10.000Z","date":"2023-11-09","kind":"other","planned":false,"acquired":false,"shares":12264,"ownership":{"direct":false,"nature":"By AD Holdings, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the \"Merger Agreement\"), by and among the Issuer, Revolution Medicines, Inc. (\"Revolution Medicines\"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines (\"Merger Sub I\"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines (\"Merger Sub II\"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the \"Effective Time\"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the \"First Merger\"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the \"Exchange Ratio\") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are held by AD Holdings, LLC, of which Marc Andreessen is a manager. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by AD Holdings, LLC (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-020291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000089924323020291/doc4.xml","form_type":"4"}},{"id":2063250,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":1,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":2,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":3,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":4,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":5,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":6,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":7,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":8,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":20480,"kind":"person","name":"HOROWITZ BENJAMIN A","position":10,"cik":"0001166586","reported_name":"HOROWITZ BENJAMIN A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Earn-out Shares","published_at":"2023-01-05T21:01:45.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":8246,"ownership":{"direct":false,"nature":"By Andreessen Horowitz LSV Fund I, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the \"AH Funds\") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the \"Earn-out Shares\"), (i) 24,265 of which will be released from escrow if the value weighted average price (\"VWAP\") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"(Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the \"AH Funds\") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the \"Earn-out Shares\"), (i) 24,265 of which will be released from escrow if the value weighted average price (\"VWAP\") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50."},{"field":"kind","element":"transactionCoding","label":"F3","text":"(Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the \"AH Funds\") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the \"Earn-out Shares\"), (i) 24,265 of which will be released from escrow if the value weighted average price (\"VWAP\") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the \"AH Funds\") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the \"Earn-out Shares\"), (i) 24,265 of which will be released from escrow if the value weighted average price (\"VWAP\") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The reported securities are held by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the \"AH LSV Fund I Entities\"). AH Equity Partners LSV I, L.L.C. (\"AH EP LSV I\") is the general partner of the AH LSV Fund I Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH LSV Fund I Entities. The managing members of AH EP LSV I are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH LSV Fund I Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":1574510,"derivative":{"expiration_date":"2024-12-17","underlying":"Common Stock","underlying_shares":8246},"source":{"system":"sec-edgar","filing":"0001104659-23-001393","document":"tm231679-13_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000110465923001393/tm231679-13_4seq1.xml","form_type":"4"}},{"id":2063249,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":1,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":2,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":3,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":4,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":5,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":6,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":7,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":8,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":20480,"kind":"person","name":"HOROWITZ BENJAMIN A","position":10,"cik":"0001166586","reported_name":"HOROWITZ BENJAMIN A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Earn-out Shares","published_at":"2023-01-05T21:01:45.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":13842,"ownership":{"direct":false,"nature":"By AH Bio Fund III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the \"AH Funds\") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the \"Earn-out Shares\"), (i) 24,265 of which will be released from escrow if the value weighted average price (\"VWAP\") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"(Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the \"AH Funds\") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the \"Earn-out Shares\"), (i) 24,265 of which will be released from escrow if the value weighted average price (\"VWAP\") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50."},{"field":"kind","element":"transactionCoding","label":"F3","text":"(Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the \"AH Funds\") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the \"Earn-out Shares\"), (i) 24,265 of which will be released from escrow if the value weighted average price (\"VWAP\") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the \"AH Funds\") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the \"Earn-out Shares\"), (i) 24,265 of which will be released from escrow if the value weighted average price (\"VWAP\") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The reported securities are held by AH Bio Fund III, L.P., for itself and as nominee for AH Bio Fund III-B, L.P. and AH Bio Fund III-Q, L.P. (collectively, the \"AH Bio Fund III Entities\"). AH Equity Partners Bio III, L.L.C. (\"AH EP Bio III\") is the general partner of the AH Bio Fund III Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH Bio Fund III Entities. The managing members of AH EP Bio III are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH Bio Fund III Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH Bio Fund III Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":2642897,"derivative":{"expiration_date":"2024-12-17","underlying":"Common Stock","underlying_shares":13842},"source":{"system":"sec-edgar","filing":"0001104659-23-001393","document":"tm231679-13_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000110465923001393/tm231679-13_4seq1.xml","form_type":"4"}},{"id":2063248,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":69704,"kind":"organization","name":"AH Equity Partners LSV I, L.L.C.","position":1,"cik":"0001772287","reported_name":"AH Equity Partners LSV I, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69701,"kind":"organization","name":"Andreessen Horowitz LSV Fund I, L.P.","position":2,"cik":"0001772284","reported_name":"Andreessen Horowitz LSV Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69702,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-B, L.P.","position":3,"cik":"0001772420","reported_name":"Andreessen Horowitz LSV Fund I-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69703,"kind":"organization","name":"Andreessen Horowitz LSV Fund I-Q, L.P.","position":4,"cik":"0001772407","reported_name":"Andreessen Horowitz LSV Fund I-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41436,"kind":"organization","name":"AH Equity Partners LSV II, L.L.C.","position":5,"cik":"0001829384","reported_name":"AH Equity Partners LSV II, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41435,"kind":"organization","name":"Andreessen Horowitz LSV Fund II, L.P.","position":6,"cik":"0001829357","reported_name":"Andreessen Horowitz LSV Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69705,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-B, L.P.","position":7,"cik":"0001829459","reported_name":"Andreessen Horowitz LSV Fund II-B, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69706,"kind":"organization","name":"Andreessen Horowitz LSV Fund II-Q, L.P.","position":8,"cik":"0001829458","reported_name":"Andreessen Horowitz LSV Fund II-Q, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10500,"kind":"person","name":"Andreessen Marc L","position":9,"cik":"0001160077","reported_name":"Andreessen Marc L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":20480,"kind":"person","name":"HOROWITZ BENJAMIN A","position":10,"cik":"0001166586","reported_name":"HOROWITZ BENJAMIN A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Earn-out Shares","published_at":"2023-01-05T21:01:45.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":12577,"ownership":{"direct":false,"nature":"By AH Bio Fund II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the \"AH Funds\") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the \"Earn-out Shares\"), (i) 24,265 of which will be released from escrow if the value weighted average price (\"VWAP\") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"(Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.)."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the \"AH Funds\") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the \"Earn-out Shares\"), (i) 24,265 of which will be released from escrow if the value weighted average price (\"VWAP\") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50."},{"field":"kind","element":"transactionCoding","label":"F3","text":"(Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the \"AH Funds\") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the \"Earn-out Shares\"), (i) 24,265 of which will be released from escrow if the value weighted average price (\"VWAP\") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the \"AH Funds\") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the \"Earn-out Shares\"), (i) 24,265 of which will be released from escrow if the value weighted average price (\"VWAP\") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are held by AH Bio Fund II, L.P., for itself and as nominee for AH Bio Fund II-B, L.P. (collectively, the \"AH Bio Fund II Entities\"). AH Equity Partners Bio II, L.L.C. (\"AH EP Bio II\") is the general partner of the AH Bio Fund II Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH Bio Fund II Entities. The managing members of AH EP Bio II are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH Bio Fund II Entities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of the securities held by the AH Bio Fund II Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":2401418,"derivative":{"expiration_date":"2024-12-17","underlying":"Common Stock","underlying_shares":12577},"source":{"system":"sec-edgar","filing":"0001104659-23-001393","document":"tm231679-13_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1160077/000110465923001393/tm231679-13_4seq1.xml","form_type":"4"}}]}